Core executives reduce the share price of Huada Gene and then fluctuate

Recently, the official website of the Ministry of Science and Technology has updated 6 pieces of punishment information. The Huada Gene ranks among them. The reason for the punishment is the leakage of genetic resources. This is the first time that the Ministry of Science and Technology has publicly disclosed administrative penalties involving human genetic resources. Huada’s gene reply has been completely rectified.

According to the relevant punishment decision book, the China Human Genetic Resources Management Office survey found that Huada Gene (Shenzhen Huada Gene Technology Service Co., Ltd.) transmitted some human genetic resources information from the Internet without permission.

According to Article 11 of the Interim Measures for the Administration of Human Genetic Resources, all international cooperation projects involving human genetic resources in China must be submitted for approval by the Chinese partner. The applicant unit shall report to the competent department according to the affiliation, and after submitting the application, submit an application to the China Human Genetic Resources Management Office, and then formally sign the contract after approval.

However, the China Human Genetic Resources Management Office survey found that Huada Gene and Shanghai Huashan Hospital (Huashan Hospital affiliated to Fudan University) conducted a Chinese large-scale case-control study on “unilateral case-control of Chinese women with unipolar depression” without permission from the University of Oxford, UK. International cooperation in resources research.

On September 7, 2015, the Ministry of Science and Technology made a decision on punishment, requiring Huashan Hospital and Huada Gene to immediately stop the aforementioned research work; destroy all undeported genetic resources materials and related research data in the aforementioned research work; stop Huashan Hospital and Huada Gene is involved in the international cooperation of China's human genetic resources and is undergoing rectification. Recently, Huada Gene responded that the company attached great importance to this matter after receiving the administrative punishment in 2015, and quickly promoted the rectification work in the first time, and re-qualified the qualification requirements, cooperation process and effect evaluation of relevant cooperation. Standardization and comprehensive rectification. At present, after verification and on-site inspection, the Ministry of Science and Technology has approved the restoration of human genetic resources for the international cooperation of human genetic resources.

However, the punishment news of the Ministry of Science and Technology still affected the stock price trend of Huada Gene in the past two days. After the opening of the market today, its share price fluctuated all the way down.

In fact, the stock price of Huada Gene has been unsatisfactory recently. In November last year, its share price climbed to a peak of 260.58 yuan per share. However, since then, it has oscillated down. The stock price has fallen to less than 50 yuan in the past 11 months. / shares, fell more than 80%. In addition to the negative events in recent months, the shareholding reduction of its internal core executives has an impact on share prices.

According to the announcement issued by Huada Gene on the evening of October 15, Shenzhen Qianhai Huada Gene Investment Enterprise (hereinafter referred to as: Huada Investment) plans to reduce the company's shares by no more than 120.03 million shares by means of block trades or centralized bidding. About 3% of the company's total share capital.

Huada Investment, the major shareholder of this reduction, is not the controlling shareholder of the company, but Wang Jun, the largest shareholder of Huada Investment, is the former CEO of Huada Gene and a director of Huada Gene. He recently resigned as a director. The fundamentals of the Huada gene should be best understood.

The initial capital contribution of Wang Jun in Huada Investment is RMB 26.85 million, which corresponds to holding 5.37332% of the equity of Huada Investment, while Huada Investment holds 669.51 million shares of Huada Gene, accounting for 16% of the total share capital. .72%. After simple conversion, it can be known that the cost per share of Huada Investment holding Huada Gene is only 0.75 yuan, after deducting 0.5% of the two cash dividends in 2018, the actual shareholding cost is only 0.25 yuan.

Of course, the lower the cost of holding shares is also to sell high prices. Now 50 yuan is also sold in the first line, and the number of sales is still quite a lot. Basically, it is necessary to top the limit of the new regulations. If all of them are reduced by bidding, they can only reduce their holdings by 2% in 6 months. Now they are holding 3%, because they are mixed with large transactions, which shows that the mood of reduction is still relatively urgent.

According to the results of the first three quarters disclosed by Huada Gene recently, the net profit attributable to shareholders of listed companies in the third quarter changed by -11.63% to 0.73%. Therefore, it means that the third quarter net profit may have a year-on-year decline.

Adult Change Robe

We are the supplier of waterproof dry robe supplier for surfing, swimming, paddle, rugby, football and etc.

We are manufacturer directly supplier for more than 8 years. Sample with Customized design and logo is available.

Features:

1. 100% recycled fabric for both outer shell and lining

2. Two big fleece pockets for warm purpose

3. YKK zip reverse puller , which ensure pull up inside.

4. Big warm hood for warm purpose.

5. Inside waterproof pocket for phones.

Sample is available now, sample time 7-10 days.

Adult Dry Robe,Change Robe Adult,Change Robes For Adults,Change Robes Adults

Suzhou Golden Gamrnet MFG Co.,Ltd , https://www.svchangerobe.com